Minerva Surgical, a Bay Area startup developing an ablation device that can curb abnormally heavy menstrual periods, just tacked on another $15 million to its cash reserve, according to a regulatory filing.
The startup last year raised $25 million for its Aurora Endometrial Ablation System, which works by sealing the cervical canal with a balloon – and then zapping the endometrial lining with an electrode array. The procedure to reduce menstruation can be completed in four minutes. See a demo here.
Minerva Surgical’s device received PMA approval from the Food and Drug Administration this past July, clearing it for commercial distribution. To date, the company’s raised nearly $100 million since its 2008 launch, according to regulatory filings. This new funding is, ostensibly, aimed at growing its commercial sales.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Clinical trials have shown that the device has reduced the amount of bleeding to normalcy in 92 percent of the women tested. In 66 percent of women, it stopped menstrual bleeding entirely. It’s aimed at women who are sure that they don’t want anymore children, and would like to stop their heavy periods.
